ロード中...
Clinical outcomes with bevacizumab-containing and non-bevacizumab–containing regimens in patients with recurrent glioblastoma from US community practices
This analysis evaluated the efficacy and safety of bevacizumab as monotherapy and with irinotecan for recurrent glioblastoma in community-based practices. Adult patients with bevacizumab-naive, recurrent glioblastoma initiating second-line treatment (July 2006–June 2010) were identified using McKess...
保存先:
| 出版年: | J Neurooncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4436682/ https://ncbi.nlm.nih.gov/pubmed/25773061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-015-1752-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|